NCT03116542 - 18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 7, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions

Essential ThrombocythemiaPrimary Myelofibrosis, Fibrotic StagePrimary Myelofibrosis, Prefibrotic Stage

Interventions

DEVICE

Diagnostic (18F-FLT PET/CT)

The tracer compound \[F-18\] FLT will be injected into the patient's veins in a small volume of normal saline solution. The PET scan data collection is started immediately and is continued for 2 hours.

Trial Locations (1)

Unknown

RECRUITING

National Center for Cancer Care & Research (NCCCR), Doha